{"PubmedArticle": [{"MedlineCitation": {"InvestigatorList": [], "SpaceFlightMission": [], "CitationSubset": ["IM"], "KeywordList": [], "GeneralNote": [], "OtherAbstract": [], "OtherID": [], "PMID": "22442992", "DateCompleted": {"Year": "2012", "Month": "04", "Day": "26"}, "DateRevised": {"Year": "2013", "Month": "11", "Day": "21"}, "Article": {"Language": ["rus"], "ELocationID": [], "ArticleDate": [], "Journal": {"ISSN": "0042-465X", "JournalIssue": {"Volume": "127", "Issue": "6", "PubDate": {"Year": "2011", "Season": "Nov-Dec"}}, "Title": "Vestnik oftalmologii", "ISOAbbreviation": "Vestn Oftalmol"}, "ArticleTitle": "[Plasmapheresis combined with cell mass ozonation in endogenous uveitis treatment].", "Pagination": {"StartPage": "32", "EndPage": "35", "MedlinePgn": "32-5"}, "Abstract": {"AbstractText": ["Authors propose a new method of uveitis treatment based on plasmapheresis in combination with cell mass ozonation. Analysis of treatment results of 3 patient groups (179 patients, 209 eyes) showed advantage of this original modification of plasmapheresis. In our opinion the effectiveness of proposed treatment option is associated with immunomodulatory effect of plasmapheresis and ozone therapy as well as bactericidal, antiviral and fungicidal effects of ozone therapy. Some sanogenetic mechanisms of the new treatment are disclosed in the study such as correction of T-cell immunodeficiency, decrease of circulating immune complexes and others."]}, "AuthorList": [{"AffiliationInfo": [], "Identifier": [], "LastName": "Onishchenko", "ForeName": "A L", "Initials": "AL"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Kolbasko", "ForeName": "A V", "Initials": "AV"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Chernysheva", "ForeName": "A D", "Initials": "AD"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Surzhikova", "ForeName": "G S", "Initials": "GS"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Dantsiger", "ForeName": "O V", "Initials": "OV"}], "PublicationTypeList": ["English Abstract", "Journal Article"]}, "MedlineJournalInfo": {"Country": "Russia (Federation)", "MedlineTA": "Vestn Oftalmol", "NlmUniqueID": "0415216", "ISSNLinking": "0042-465X"}, "ChemicalList": [{"RegistryNumber": "66H7ZZK23N", "NameOfSubstance": "Ozone"}], "MeshHeadingList": [{"QualifierName": [], "DescriptorName": "Adult"}, {"QualifierName": [], "DescriptorName": "Humans"}, {"QualifierName": [], "DescriptorName": "Male"}, {"QualifierName": [], "DescriptorName": "Middle Aged"}, {"QualifierName": ["therapeutic use"], "DescriptorName": "Ozone"}, {"QualifierName": ["methods"], "DescriptorName": "Plasmapheresis"}, {"QualifierName": ["pathology", "therapy"], "DescriptorName": "Uveitis"}, {"QualifierName": [], "DescriptorName": "Young Adult"}]}, "PubmedData": {"ReferenceList": [], "History": [{"Year": "2012", "Month": "3", "Day": "27", "Hour": "6", "Minute": "0"}, {"Year": "2012", "Month": "3", "Day": "27", "Hour": "6", "Minute": "0"}, {"Year": "2012", "Month": "4", "Day": "27", "Hour": "6", "Minute": "0"}], "PublicationStatus": "ppublish", "ArticleIdList": ["22442992"]}}], "PubmedBookArticle": []}